Celimmune LLC

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Amgen Links With Provention

Start-up biotechs engaged in a dealmaking frenzy in 2015, signing almost twice the number of alliances penned in 2014. Regenerative medicine technologies were the key drivers behind some of the most l

IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out